Cargando…

Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies

Background: The usefulness of myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) for the assessment of idiopathic inflammatory myopathies (IIMs) is acknowledged, but laboratory standardization remains a challenge. We detected MSAs/MAAs by multi-analytic line immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghirardello, Anna, Gatto, Mariele, Franco, Chiara, Zanatta, Elisabetta, Padoan, Roberto, Ienna, Luana, Gallo, Nicoletta, Zen, Margherita, Lundberg, Ingrid E., Mahler, Michael, Doria, Andrea, Iaccarino, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572214/ https://www.ncbi.nlm.nih.gov/pubmed/37835823 http://dx.doi.org/10.3390/diagnostics13193080

Ejemplares similares

Myositis autoantibodies and clinical phenotypes
por: Ghirardello, Anna, et al.
Publicado: (2014)

Drugs in induction and treatment of idiopathic inflammatory myopathies
por: Iaccarino, Luca, et al.
Publicado: (2014)

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG Anti-dsDNA Help to Identify Glomerulonephritis and Active Disease
por: Villalta, Danilo, et al.
Publicado: (2013)

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
por: Trentin, Francesca, et al.
Publicado: (2018)

Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
por: Trentin, Francesca, et al.
Publicado: (2018)

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
por: Tansley, Sarah L, et al.
Publicado: (2020)

Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and Disease
por: Franco, Chiara, et al.
Publicado: (2023)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
por: Tansley, Sarah L., et al.
Publicado: (2020)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies
por: Perron, Megan Mariko, et al.
Publicado: (2021)

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies
por: Mahler, Michael, et al.
Publicado: (2019)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience
por: Gudipati, Archana, et al.
Publicado: (2023)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
por: Betteridge, Z., et al.
Publicado: (2019)

SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients
por: Zen, M., et al.
Publicado: (2020)

Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation
por: Iaccarino, L., et al.
Publicado: (2014)

Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis
por: Gatto, Mariele, et al.
Publicado: (2022)

Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies
por: Amlani, Adam, et al.
Publicado: (2022)

Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis
por: Li, Liubing, et al.
Publicado: (2020)

Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
por: Yang, Hanbo, et al.
Publicado: (2017)

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features
por: Yasin, S. A., et al.
Publicado: (2019)

Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy
por: Beam, Michael J., et al.
Publicado: (2023)

Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies
por: Mahler, Michael, et al.
Publicado: (2021)

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
por: Mammen, Andrew L., et al.
Publicado: (2015)

Diagnostic Value of Muscle Ultrasound for Myopathies and Myositis
por: Albayda, Jemima, et al.
Publicado: (2020)

Myositis and myopathy of sarcoidosis: A case report
por: Burr, Tucker v R., et al.
Publicado: (2020)

Bench to bedside review of myositis autoantibodies
por: Palterer, Boaz, et al.
Publicado: (2018)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis
por: Rahmé, Zahrà, et al.
Publicado: (2023)

Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
por: Yang, Hanbo, et al.
Publicado: (2018)

Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy
por: Yu, Zhen, et al.
Publicado: (2021)

Prevalence of Myositis-Specific Autoantibodies and Myositis-Associated Autoantibodies in COVID-19 Patients: A Pilot Study and Literature Review
por: Swartzman, Isaac, et al.
Publicado: (2022)

Effect of pregnancy on serum cytokines in SLE patients
por: Doria, Andrea, et al.
Publicado: (2012)

Acute Hemorrhagic Myositis in Inflammatory Myopathy and Review of the Literature
por: Van Gelder, Howard, et al.
Publicado: (2014)

Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?
por: Kiran, Aneeta R., et al.
Publicado: (2016)

Myositis-specific autoantibodies: detection and clinical associations
por: van Dooren, Sander H. J., et al.
Publicado: (2011)

Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
por: García-De La Torre, Ignacio
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7of3jqvqm8e6l3sv5sfa5lm1jn